Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuval Ishay

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Immunopathology and Pharmacology|November 18, 2021
The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathwaysYuval Ishay, Dvorah Rotnemer-Golinkin, Yaron Ilan
American Journal of Physiology. Cell Physiology|March 5, 2020
The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapiesYuval Ishay, Dean Nachman, Tawfik Khoury, et al.
Hepatology Communications|September 9, 2020
Antibody Response to Severe Acute Respiratory Syndrome- Corona Virus 2, Diagnostic and Therapeutic ImplicationsYuval Ishay, Asa Kessler, Asaf Schwarts, et al.
Acta Haematologica|May 17, 2021
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid SyndromeRam Gelman, Fadi Kharouf, Yuval Ishay, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 4, 2021
Role of circadian rhythm and autonomic nervous system in liver function: a hypothetical basis for improving the management of hepatic encephalopathyYuval Ishay, Yotam Kolben, Asa Kessler, et al.
Clinical Immunology (Orlando, Fla.)|April 10, 2021
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based productsAriel Kenig, Yuval Ishay, Fadi Kharouf, et al.
Autoimmune Diseases|September 16, 2022
Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center ExperienceYuval Ishay, Ariel Kenig, Limor Rubin, et al.
Rheumatology (Oxford, England)|July 22, 2021
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean feverFadi Kharouf, Yuval Ishay, Ariel Kenig, et al.
Drug Development Research|October 1, 2021
Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID-19Yuval Ishay, Assaf Potruch, Sarah Weksler-Zangen, et al.
Blood Cells, Molecules & Diseases|November 22, 2016
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug developmentYuval Ishay, Ari Zimran, Jeffrey Szer, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Immunopathology and Pharmacology|November 18, 2021
The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathwaysYuval Ishay, Dvorah Rotnemer-Golinkin, Yaron Ilan
American Journal of Physiology. Cell Physiology|March 5, 2020
The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapiesYuval Ishay, Dean Nachman, Tawfik Khoury, et al.
Hepatology Communications|September 9, 2020
Antibody Response to Severe Acute Respiratory Syndrome- Corona Virus 2, Diagnostic and Therapeutic ImplicationsYuval Ishay, Asa Kessler, Asaf Schwarts, et al.
Acta Haematologica|May 17, 2021
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid SyndromeRam Gelman, Fadi Kharouf, Yuval Ishay, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 4, 2021
Role of circadian rhythm and autonomic nervous system in liver function: a hypothetical basis for improving the management of hepatic encephalopathyYuval Ishay, Yotam Kolben, Asa Kessler, et al.
Clinical Immunology (Orlando, Fla.)|April 10, 2021
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based productsAriel Kenig, Yuval Ishay, Fadi Kharouf, et al.
Autoimmune Diseases|September 16, 2022
Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center ExperienceYuval Ishay, Ariel Kenig, Limor Rubin, et al.
Rheumatology (Oxford, England)|July 22, 2021
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean feverFadi Kharouf, Yuval Ishay, Ariel Kenig, et al.
Drug Development Research|October 1, 2021
Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID-19Yuval Ishay, Assaf Potruch, Sarah Weksler-Zangen, et al.
Blood Cells, Molecules & Diseases|November 22, 2016
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug developmentYuval Ishay, Ari Zimran, Jeffrey Szer, et al.
Pageof 3